Search
Bristol-Myers Squibb Co
BMYAdd to Watchlist
61.530USD
+0.770+1.27%
Close 07-23 16:00（ET）Quotes delayed by 15 min
123.86BMarket Cap
17.22P/E TTM
BMY Financials
See Bristol-Myers Squibb Co's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Bristol-Myers Squibb Co Earnings Date
Latest Release
Jul 30, 2026
EPS / Forecast
--/1.59
Revenue / Forecast
--/11.74B
Period
FY2025 Earnings
Revenue(YoY)
48.19B
-0.22%
EPS(YoY)
3.47
178.56%
Analyst Rating
HOLD
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its total revenue reached 48.19B, with a year-on-year change of 48.30B.
What are the current assets of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its current assets were 29.39B, with a year-on-year change of -1.31.
What are the total assets of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its total assets of Bristol-Myers Squibb Co were 90.04B, with a year-on-year change of -2.77.
What are the total liabilities of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its total liabilities of Bristol-Myers Squibb Co were 71.53B, with a year-on-year change of -6.14.
What is the total equity of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its total equity of Bristol-Myers Squibb Co was 18.51B, with a year-on-year change of 12.92.
What is the net operating income of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its net operating income of Bristol-Myers Squibb Co was 17.26B, with a year-on-year change of 49.54.
What is the net investment of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its net investment of Bristol-Myers Squibb Co was -4.13B, with a year-on-year change of 80.65.
What is the net financing of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its net financing of Bristol-Myers Squibb Co was -10.35B, with a year-on-year change of -301.83.
What is the Earnings Per Share (EPS) of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its Earnings Per Share (EPS) was 3.47, with a year-on-year change of 178.56.
What is the net income of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its net income was 7.05B, with a year-on-year change of 178.83.
What is the net margin of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its net profit margin was 14.64, with a year-on-year change of 179.15.
What is the gross margin of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its gross margin was 65.74, with a year-on-year change of 15.55.
What is the debt-to-asset ratio of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its debt-to-asset ratio was 50.10, with a year-on-year change of -6.55.
What is the Return on Equity (ROE) of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Equity (ROE) was 40.53, with a year-on-year change of 203.65.
What is the Return on Assets (ROA) of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Assets (ROA) was 7.73, with a year-on-year change of 181.19.
What is the operating profit of Bristol-Myers Squibb Co?
According to Bristol-Myers Squibb Co's FY2025 earnings report, its operating profit was 17.26B, with a year-on-year change of 49.54.